Infectious Agents Identified by Real-Time PCR, Serology and Bacteriology in Blood and Peritoneal Exudate Samples of Cows Affected by Parietal Fibrinous Peritonitis after Caesarean Section
The aim of this study was to identify the pathogens potentially involved in parietal fibrinous peritonitis (PFP). PFP is a complication of laparotomy in cattle, characterized by an accumulation of exudate inside a fibrinous capsule. We have studied 72 cases of PFP in Belgian blue cows, confirmed by a standard diagnostic protocol. Blood was collected to evaluate the presence of antibodies for Mycoplasma bovis(M. bovis), Coxiella burnetii(C. burnetii) and Bovine Herpesvirus 4(BoHV4) by enzyme-linked immunosorbent assays.
Peritoneal exudate was obtained from the PFP cavity to perform bacteriological culture, and to identify the DNA of M. bovis, C. burnetii and BoHV4 using real time polymerase chain reaction (qPCR). Bacteriological culture was positive in most peritoneal samples (59/72); Trueperella pyogenes (T. pyogenes) (51/72) and Escherichia coli (E. coli) (20/72) were the most frequently identified. For BoHV4, the majority of cows showed positive serology and qPCR (56/72 and 49/72, respectively).
Contrariwise, M. bovis (17/72 and 6/72, respectively) and C. burnetii (15/72 and 6/72, respectively) were less frequently detected (p < 0.0001). Our study proves that PFP can no longer be qualified as a sterile inflammation. Moreover, we herein describe the first identification of BoHV4 and C. burnetii in cows affected by PFP.
Pressinoic Acid |
|||
| 5-01806 | CHI Scientific | 4 x 5mg | Ask for price |
Carnosic Acid |
|||
| 2075-25 | Biovision | EUR 523.2 | |
Carnosic Acid |
|||
| 2075-5 | Biovision | EUR 176.4 | |
MB acid |
|||
| 40076 | Biotium | 5MG | EUR 384 |
|
Description: Minimum order quantity: 1 unit of 5MG |
|||
Mycophenolic acid |
|||
| 10-030 | ProSci | 500 mg | EUR 539.16 |
|
Description: Antibiotic [1]. Shows antiviral, antifungal and antitumor properties [1, 2]. Immunosuppressive drug used to prevent rejection in organ transplantation, rheumatoid arthritis, and psoriasis [3-6, 13]. Potent reversible inhibitor of inosine-5'-monophosphate dehydrogenase (IMPDH), leading to depletion of GMP and interruption of the de novo synthesis of purine nucleotides necessary for B and T lymphocyte proliferation [7, 8]. Inhibits the type II IMPDH isoform (IMPDH-2) 5-fold more potently compared to type I isoform [11]. Inhibits RNA and DNA synthesis [13]. Inducible nitric oxide synthase (iNOS/NOS II) inhibitor [8, 10]. Apoptosis and necrosis inducer [9, 12]. Novel type of inhibitor against RNA guanylyltransferases [14]. Inhibits TNF-α-stimulated MAPK/NF-κB and ROS generation [15]. Autophagy suppressor. Broad-spectrum antiviral compound with inhibitory activity against different coronavirus, including SARS-CoV, MERS-CoV and SARS-CoV-2, cause of COVID-19. It binds to the active site of SARS-CoV-2 papain-like protease (PLpro) possibly inhibiting viral replication. |
|||
Oleanolic Acid |
|||
| 1731-100 | Biovision | EUR 138 | |
Oleanolic Acid |
|||
| 1731-500 | Biovision | EUR 398.4 | |
Rosmarinic Acid |
|||
| 1843-250 | Biovision | EUR 274.8 | |
Rosmarinic Acid |
|||
| 1843-50 | Biovision | EUR 138 | |
Anacardic Acid |
|||
| 1849-25 | Biovision | EUR 444 | |
Anacardic Acid |
|||
| 1849-5 | Biovision | EUR 176.4 | |
Mycophenolic Acid |
|||
| 1882-250 | Biovision | EUR 352.8 | |
Mycophenolic Acid |
|||
| 1882-50 | Biovision | EUR 138 | |
ICG acid |
|||
| 189 | AAT Bioquest | 5 mg | EUR 262.8 |
Arachidonic Acid |
|||
| 1505-100 | Biovision | EUR 202.8 | |
Aurintricarboxylic acid |
|||
| 1506-1000 | Biovision | EUR 164.4 | |
Okadaic acid |
|||
| 1543-025 | Biovision | EUR 188.4 | |
Okadaic acid |
|||
| 1543-100 | Biovision | EUR 379.2 | |
Betulinic acid |
|||
| 1552-100 | Biovision | EUR 450 | |
Betulinic acid |
|||
| 1552-25 | Biovision | EUR 170.4 | |
Lithocholic acid |
|||
| 2187-1G | Biovision | EUR 138 | |
Lithocholic acid |
|||
| 2187-5G | Biovision | EUR 326.4 | |
Heptelidic Acid |
|||
| 2215-1000 | Biovision | EUR 588 | |
Heptelidic Acid |
|||
| 2215-250 | Biovision | EUR 261.6 | |
Retinoic acid |
|||
| 2218-250 | Biovision | EUR 405.6 | |
Retinoic acid |
|||
| 2218-50 | Biovision | EUR 151.2 | |
Kainic acid |
|||
| 2279-25 | Biovision | EUR 457.2 | |
Kainic acid |
|||
| 2279-5 | Biovision | EUR 170.4 | |
Caffeic acid |
|||
| 2303-250 | Biovision | EUR 235.2 | |
Caffeic acid |
|||
| 2303-50 | Biovision | EUR 117.6 | |
Gambogic acid |
|||
| 2785-25 | Biovision | EUR 652.8 | |
Gambogic acid |
|||
| 2785-5 | Biovision | EUR 210 | |
Chenodeoxycholic acid |
|||
| 2831-1G | Biovision | EUR 144 | |
Chenodeoxycholic acid |
|||
| 2831-25G | Biovision | EUR 574.8 | |
Chenodeoxycholic acid |
|||
| 2831-5G | Biovision | EUR 222 | |
(+)-Abscisic acid |
|||
| 2543-1 | Biovision | EUR 144 | |
(+)-Abscisic acid |
|||
| 2543-5 | Biovision | EUR 379.2 | |
Itaconic acid |
|||
| 2576-1G | Biovision | EUR 144 | |
Itaconic acid |
|||
| 2576-5G | Biovision | EUR 288 | |
Ellagic acid |
|||
| A2306-25 | ApexBio | 25 mg | EUR 199.2 |
|
Description: Selective, ATP-competitive inhibitor of casein kinase 2 (CK2) (IC50 values are 40, 2900, 3500, 4300 and 9400 nM for CK2, Lyn, PKA, Syk?and FGR respectively). Exhibits antioxidant, antitumor and anticarcinogenic activity and also inhibits glutat |
|||
Ellagic acid |
|||
| A2306-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 129.6 |
|
Description: Selective, ATP-competitive inhibitor of casein kinase 2 (CK2) (IC50 values are 40, 2900, 3500, 4300 and 9400 nM for CK2, Lyn, PKA, Syk?and FGR respectively). Exhibits antioxidant, antitumor and anticarcinogenic activity and also inhibits glutat |
|||
Betulinic acid |
|||
| A3237-100 | ApexBio | 100 mg | EUR 129.6 |
|
Description: Betulinic acid is a natural pentacyclic triterpenoid that displays anti-HIV and antitumor activity. Betulinic acid selectively induces apoptosis in tumor cells by directly activating the mitochondrial pathway of apoptosis through a p53- and CD95-independent mechanism. |
|||
Betulinic acid |
|||
| A3237-200 | ApexBio | 200 mg | EUR 177.6 |
|
Description: Betulinic acid is a natural pentacyclic triterpenoid that displays anti-HIV and antitumor activity. Betulinic acid selectively induces apoptosis in tumor cells by directly activating the mitochondrial pathway of apoptosis through a p53- and CD95-independent mechanism. |
|||
Betulinic acid |
|||
| A3237-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 129.6 |
|
Description: Betulinic acid is a natural pentacyclic triterpenoid that displays anti-HIV and antitumor activity. Betulinic acid selectively induces apoptosis in tumor cells by directly activating the mitochondrial pathway of apoptosis through a p53- and CD95-independent mechanism. |
|||
Betulinic acid |
|||
| A3237-500 | ApexBio | 500 mg | EUR 309.6 |
|
Description: Betulinic acid is a natural pentacyclic triterpenoid that displays anti-HIV and antitumor activity. Betulinic acid selectively induces apoptosis in tumor cells by directly activating the mitochondrial pathway of apoptosis through a p53- and CD95-independent mechanism. |
|||
Gambogic Acid |
|||
| A3424-10 | ApexBio | 10 mg | EUR 192 |
|
Description: Gambogic acid (GA) is an inducer of apoptosis with EC50 value of 0.78-1.64 ?M for caspases and with IC50 values of 1.47, 1.21, 2.02, 0.66, 1.06 and 0.79 ?M for Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1, respectively. |
|||
Gambogic Acid |
|||
| A3424-25 | ApexBio | 25 mg | EUR 261.6 |
|
Description: Gambogic acid (GA) is an inducer of apoptosis with EC50 value of 0.78-1.64 ?M for caspases and with IC50 values of 1.47, 1.21, 2.02, 0.66, 1.06 and 0.79 ?M for Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1, respectively. |
|||
Gambogic Acid |
|||
| A3424-5 | ApexBio | 5 mg | EUR 150 |
|
Description: Gambogic acid (GA) is an inducer of apoptosis with EC50 value of 0.78-1.64 ?M for caspases and with IC50 values of 1.47, 1.21, 2.02, 0.66, 1.06 and 0.79 ?M for Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1, respectively. |
|||
Gambogic Acid |
|||
| A3424-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 184.8 |
|
Description: Gambogic acid (GA) is an inducer of apoptosis with EC50 value of 0.78-1.64 ?M for caspases and with IC50 values of 1.47, 1.21, 2.02, 0.66, 1.06 and 0.79 ?M for Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1, respectively. |
|||
Anacardic acid |
|||
| A4488-10 | ApexBio | 10 mg | EUR 142.8 |
|
Description: IC50: Noncompetitively inhibit histone acetyltransferase (HAT) activity in prostate cancer with an IC50 value of about 5.0 M.Anacardic acid (AA) is commonly regarded as a non-specific HAT inhibitor of p300. |
|||
Anacardic acid |
|||
| A4488-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 129.6 |
|
Description: IC50: Noncompetitively inhibit histone acetyltransferase (HAT) activity in prostate cancer with an IC50 value of about 5.0 M.Anacardic acid (AA) is commonly regarded as a non-specific HAT inhibitor of p300. |
|||
Anacardic acid |
|||
| A4488-50 | ApexBio | 50 mg | EUR 393.6 |
|
Description: IC50: Noncompetitively inhibit histone acetyltransferase (HAT) activity in prostate cancer with an IC50 value of about 5.0 M.Anacardic acid (AA) is commonly regarded as a non-specific HAT inhibitor of p300. |
|||
Okadaic acid |
|||
| A4540-.05 | ApexBio | 50 µg | EUR 182.4 |
|
Description: Okadaic acid is a potent inhibitor of protein phosphatase 1/2A with IC50 values of 19 nM and 0.2 nM for protein phosphatase 1 and protein phosphatase 2A, respectively [1]. |
|||
Okadaic acid |
|||
| A4540-.1 | ApexBio | 100 µg | EUR 292.8 |
|
Description: Okadaic acid is a potent inhibitor of protein phosphatase 1/2A with IC50 values of 19 nM and 0.2 nM for protein phosphatase 1 and protein phosphatase 2A, respectively [1]. |
|||
Abscisic Acid |
|||
| abx082046-100mg | Abbexa | 100 mg | EUR 243.6 |
Folic acid |
|||
| abx082263-100g | Abbexa | 100 g | EUR 376.8 |
Folic acid |
|||
| 20-abx082265 | Abbexa |
|
|
Nicotinic acid |
|||
| 20-abx082297 | Abbexa |
|
|
Maleic acid |
|||
| abx082326-100g | Abbexa | 100 g | EUR 226.8 |
Pyruvic acid |
|||
| 20-abx082337 | Abbexa |
|
|
Boric acid |
|||
| abx082355-500g | Abbexa | 500 g | EUR 243.6 |
Gibberellic acid |
|||
| 20-abx082365 | Abbexa |
|
|
Boric acid |
|||
| abx082375-500g | Abbexa | 500 g | EUR 226.8 |
Pyruvic acid |
|||
| 20-abx082493 | Abbexa |
|
|
Lipoteichoic Acid |
|||
| abx087002-1mg | Abbexa | 1 mg | EUR 343.2 |
Calconcarboxylic Acid |
|||
| abx090682-25g | Abbexa | 25 g | EUR 243.6 |
Carnosic acid |
|||
| 20-abx076520 | Abbexa |
|
|
Betulinic Acid |
|||
| 20-abx076536 | Abbexa |
|
|
Kainic acid |
|||
| 20-abx076647 | Abbexa |
|
|
Quisqualic Acid |
|||
| 20-abx076651 | Abbexa |
|
|
Retinoic acid |
|||
| 20-abx076656 | Abbexa |
|
|
Okadaic acid |
|||
| 20-abx076703 | Abbexa |
|
|
(+)-Abscisic Acid |
|||
| abx076833-1mg | Abbexa | 1 mg | EUR 493.2 |
Tropodithietic acid |
|||
| abx076844-1mg | Abbexa | 1 mg | EUR 477.6 |
Piromidic Acid |
|||
| A8502-10 | ApexBio | 10 mg | EUR 129.6 |
|
Description: Shown to have antibacterial properties. |
|||
Piromidic Acid |
|||
| A8502-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 129.6 |
|
Description: Shown to have antibacterial properties. |
|||
Piromidic Acid |
|||
| A8502-50 | ApexBio | 50 mg | EUR 199.2 |
|
Description: Shown to have antibacterial properties. |
|||
Ascorbic acid |
|||
| A8158-10 | ApexBio | 10 mg | EUR 170.4 |
|
Description: Ascorbic acid is the recommended reagent for the reduction of Copper(II)-TBTA complex into active Copper(I) form. |
|||
Lithocholic Acid |
|||
| A8463-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 135.6 |
|
Description: Lithocholic acid (LCA) is a toxic secondary bile acid, causing intrahepatic cholestasis, which has tumor-promoting activity. |
|||
Lithocholic Acid |
|||
| A8463-50 | ApexBio | 50 mg | EUR 157.2 |
|
Description: Lithocholic acid (LCA) is a toxic secondary bile acid, causing intrahepatic cholestasis, which has tumor-promoting activity. |
|||
Nordihydroguaiaretic acid |
|||
| A3664-100 | ApexBio | 100 mg | EUR 126 |
|
Description: Description: IC50 Value: N/A Nordihydroguaiaretic acid (NDGA) is a natural phenolic compound isolated from the creosote bush Larrea divaricata, which has anti-tumor activities both in vitro and in vivo. |
|||
Nordihydroguaiaretic acid |
|||
| A3664-500 | ApexBio | 500 mg | EUR 195.6 |
|
Description: Description: IC50 Value: N/A Nordihydroguaiaretic acid (NDGA) is a natural phenolic compound isolated from the creosote bush Larrea divaricata, which has anti-tumor activities both in vitro and in vivo. |
|||
Oseltamivir acid |
|||
| A3689-10 | ApexBio | 10 mg | EUR 172.8 |
|
Description: Oseltamivir is an inhibitor of influenza neuraminidase [1].Oseltamivir is a prodrug that is converted by intestinal and/or hepatic esterases to the neuraminidase inhibitor molecule, oseltamivir carboxylate. |
|||
Oseltamivir acid |
|||
| A3689-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 129.6 |
|
Description: Oseltamivir is an inhibitor of influenza neuraminidase [1].Oseltamivir is a prodrug that is converted by intestinal and/or hepatic esterases to the neuraminidase inhibitor molecule, oseltamivir carboxylate. |
|||
Oseltamivir acid |
|||
| A3689-50 | ApexBio | 50 mg | EUR 315.6 |
|
Description: Oseltamivir is an inhibitor of influenza neuraminidase [1].Oseltamivir is a prodrug that is converted by intestinal and/or hepatic esterases to the neuraminidase inhibitor molecule, oseltamivir carboxylate. |
|||
Anacardic Acid |
|||
| A160-10MG | TOKU-E | 10mg | EUR 144 |
Anacardic Acid |
|||
| A160-250MG | TOKU-E | 250mg | EUR 298.8 |
Glycerophosphoric acid |
|||
| 20-abx180002 | Abbexa |
|
|
Cyclobutylboronic Acid |
|||
| 20-abx180715 | Abbexa |
|
|
Hendecanoic acid |
|||
| 20-abx180775 | Abbexa |
|
|
Heptadecanoic acid |
|||
| 20-abx180776 | Abbexa |
|
|
Methanesulfonylacetic Acid |
|||
| 20-abx180797 | Abbexa |
|
|
Octadecanedioic acid |
|||
| 20-abx180854 | Abbexa |
|
|
pentadecanoic acid |
|||
| 20-abx180857 | Abbexa |
|
|
Pyromeconic acid |
|||
| 20-abx180870 | Abbexa |
|
|
Tridecanoic acid |
|||
| 20-abx180912 | Abbexa |
|
|
Cyclopentylboronic Acid |
|||
| 20-abx181255 | Abbexa |
|
|
Cyclopropylacetic acid |
|||
| 20-abx181256 | Abbexa |
|
|
Hydroxymalonic acid |
|||
| 20-abx181299 | Abbexa |
|
|
Tridecanedioic acid |
|||
| 20-abx181373 | Abbexa |
|
|
Coumalic acid |
|||
| 20-abx182402 | Abbexa |
|
|
Cyclohexylboronic Acid |
|||
| 20-abx182406 | Abbexa |
|
|
Ethylboronic Acid |
|||
| 20-abx182474 | Abbexa |
|
|
Isopropylboronic Acid |
|||
| 20-abx182498 | Abbexa |
|
|
Methylboronic Acid |
|||
| 20-abx182574 | Abbexa |
|
|
oxalic acid |
|||
| 20-abx182613 | Abbexa |
|
|
Chenodeoxycholic acid |
|||
| abx183934-100g | Abbexa | 100 g | EUR 276 |
Cholic acid |
|||
| abx183940-100g | Abbexa | 100 g | EUR 360 |
Cyclopropylboronic Acid |
|||
| 20-abx183964 | Abbexa |
|
|
Diclofenac acid |
|||
| 20-abx183982 | Abbexa |
|
|
Heptafluorobutyric acid |
|||
| 20-abx184109 | Abbexa |
|
|
Hexadecanedioic acid |
|||
| 20-abx184111 | Abbexa |
|
|
Nipecotic acid |
|||
| 20-abx184279 | Abbexa |
|
|
Oleanolic acid |
|||
| 20-abx184292 | Abbexa |
|
|
Tetrachlorophthalic acid |
|||
| abx184419-25g | Abbexa | 25 g | EUR 260.4 |
Tetradecanedioic acid |
|||
| 20-abx184421 | Abbexa |
|
|
Vanillic acid |
|||
| abx184472-500g | Abbexa | 500 g | EUR 493.2 |
Zoledronic acid |
|||
| 20-abx184486 | Abbexa |
|
|
Nitrilotriacetic acid |
|||
| 20-abx184498 | Abbexa |
|
|
Cyclohexanepropionic acid |
|||
| abx184664-500ml | Abbexa | 500 ml | EUR 844.8 |
Deoxycholic acid |
|||
| 20-abx184668 | Abbexa |
|
|
Identification of the RNase-binding site of SARS-CoV-2 RNA for anchor primer-PCR detection of viral loading in 306 COVID-19 patients
The pandemic of coronavirus disease 2019 (COVID-19) urgently calls for more sensitive molecular diagnosis to improve sensitivity of current viral nuclear acid detection. We have developed an anchor primer (AP)-based assay to improve viral RNA stability by bioinformatics identification of RNase-binding site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and implementing AP dually targeting the N gene of SARS-CoV-2 RNA and RNase 1, 3, 6.
The arbitrarily primed polymerase chain reaction (AP-PCR) improvement of viral RNA integrity was supported by (a) the AP increased resistance of the targeted gene (N gene) of SARS-CoV-2 RNA to RNase treatment; (b) the detection of SARS-CoV-2 RNA by AP-PCR with lower cycle threshold values (-2.7 cycles) compared to two commercially available assays; (c) improvement of the viral RNA stability of the ORF gene upon targeting of the N gene and RNase. Furthermore, the improved sensitivity by AP-PCR was demonstrated by detection of SARS-CoV-2 RNA in 70-80% of sputum, nasal, pharyngeal swabs and feces and 36% (4/11) of urine of the confirmed cases (n = 252), 7% convalescent cases (n = 54) and none of 300 negative cases. Lastly, AP-PCR analysis of 306 confirmed and convalescent cases revealed prolonged presence of viral loading for >20 days after the first positive diagnosis.
Thus, the AP dually targeting SARS-CoV-2 RNA and RNase improves molecular detection by preserving SARS-CoV-2 RNA integrity and reveals the prolonged viral loading associated with older age and male gender in COVID-19 patients.
Rapid and Efficient Colony-PCR for High Throughput Screening of Genetically Transformed Chlamydomonas reinhardtii
Microalgae biotechnologies are rapidly developing into new commercial settings. Several high value products already exist on the market, and biotechnological development is focused on genetic engineering of microalgae to open up future economic opportunities for food, fuel and pharmacological production. Colony-polymerase chain reaction (colony-PCR or cPCR) is a critical method for screening genetically transformed microalgae cells.
However, the ability to rapidly screen thousands of transformants using the current colony-PCR method, becomes a very laborious and time-consuming process. Herein, the non-homologous transformation of Chlamydomonas reinhardtii using the electroporation and glass beads methods generated more than seven thousand transformants. In order to manage this impressive number of clones efficiently, we developed a high-throughput screening (HTS) cPCR method to rapidly maximize the detection and selection of positively transformed clones.
For this, we optimized the Chlamydomonas transformed cell layout on the culture media to improve genomic DNA extraction and cPCR in 96-well plate. The application of this optimized HTS cPCR method offers a rapid, less expensive and reliable method for the detection and selection of microalgae transformants.
Our method, which saves up to 80% of the experimental time, holds promise for evaluating genetically transformed cells and selection for microalgae-based biotechnological applications such as synthetic biology and metabolic engineering.
ART5 Antibody |
|||
| 1-CSB-PA836246LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against ART5. Recognizes ART5 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:100-1:1000 |
|||
ART5 Antibody |
|||
| 1-CSB-PA889866 | Cusabio |
|
|
|
Description: A polyclonal antibody against ART5. Recognizes ART5 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:100-1:300 |
|||
ART5 Antibody |
|||
| 1-CSB-PA219850 | Cusabio |
|
|
|
Description: A polyclonal antibody against ART5. Recognizes ART5 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:10000, IHC:1:100-1:300 |
|||
Art5/ Rat Art5 ELISA Kit |
|||
| ELI-20661r | Lifescience Market | 96 Tests | EUR 1063.2 |
ART5 Conjugated Antibody |
|||
| C36155 | SAB | 100ul | EUR 476.4 |
Anti-ART5 antibody |
|||
| PAab00615 | Lifescience Market | 100 ug | EUR 463.2 |
anti- ART5 antibody |
|||
| FNab00615 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against ART5 |
|||
Anti-ART5 antibody |
|||
| STJ29226 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: The protein encoded by this gene belongs to the ARG-specific ADP-ribosyltransferase family. Proteins in this family regulate the function of target proteins by attaching ADP-ribose to specific amino acid residues in their target proteins. The mouse homolog lacks a glycosylphosphatidylinositol-anchor signal sequence and is predicted to be a secretory enzyme. Several transcripts encoding different isoforms have been found for this gene. |
|||
ART5 Polyclonal Antibody |
|||
| A66466-020 | EpiGentek | 20 ul | EUR 117.7 |
ART5 Polyclonal Antibody |
|||
| A66466-050 | EpiGentek | 50 ul | EUR 302.5 |
ART5 Polyclonal Antibody |
|||
| A66466-100 | EpiGentek | 100 ul | EUR 423.5 |
ART5 Polyclonal Antibody |
|||
| A66466 | EpiGentek |
|
|
ART5 Polyclonal Antibody |
|||
| A72754 | EpiGentek |
|
|
ART5 Polyclonal Antibody |
|||
| A72754-050 | EpiGentek | 50 ul | EUR 302.5 |
ART5 Polyclonal Antibody |
|||
| A72754-100 | EpiGentek | 100 ul | EUR 423.5 |
ART5 siRNA |
|||
| 20-abx900464 | Abbexa |
|
|
ART5 siRNA |
|||
| 20-abx908254 | Abbexa |
|
|
ART5 siRNA |
|||
| 20-abx908255 | Abbexa |
|
|
anti-ART5 |
|||
| YF-PA21994 | Abfrontier | 50 ul | EUR 435.6 |
|
Description: Mouse polyclonal to ART5 |
|||
anti-ART5 |
|||
| YF-PA21995 | Abfrontier | 50 ug | EUR 435.6 |
|
Description: Mouse polyclonal to ART5 |
|||
anti-ART5 |
|||
| YF-PA21996 | Abfrontier | 50 ul | EUR 435.6 |
|
Description: Mouse polyclonal to ART5 |
|||
anti-ART5 |
|||
| YF-PA21997 | Abfrontier | 50 ug | EUR 435.6 |
|
Description: Mouse polyclonal to ART5 |
|||
ART5 Antibody, HRP conjugated |
|||
| 1-CSB-PA836246LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against ART5. Recognizes ART5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
ART5 Antibody, FITC conjugated |
|||
| 1-CSB-PA836246LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against ART5. Recognizes ART5 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
ART5 Antibody, Biotin conjugated |
|||
| 1-CSB-PA836246LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against ART5. Recognizes ART5 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
ART5 Blocking Peptide |
|||
| 33R-9536 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ART5 antibody, catalog no. 70R-5344 |
|||
ART5 Rabbit pAb |
|||
| A7146-100ul | Abclonal | 100 ul | EUR 369.6 |
ART5 Rabbit pAb |
|||
| A7146-200ul | Abclonal | 200 ul | EUR 550.8 |
ART5 Rabbit pAb |
|||
| A7146-20ul | Abclonal | 20 ul | EUR 219.6 |
ART5 Rabbit pAb |
|||
| A7146-50ul | Abclonal | 50 ul | EUR 267.6 |
ART5 cloning plasmid |
|||
| CSB-CL836246HU-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the ART5 gene. |
|||
ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| 20-abx006905 | Abbexa |
|
|
ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| 20-abx110890 | Abbexa |
|
|
ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| abx030620-400ul | Abbexa | 400 ul | EUR 627.6 |
ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| abx030620-80l | Abbexa | 80 µl | EUR 343.2 |
ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| 20-abx212387 | Abbexa |
|
|
ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| 20-abx212388 | Abbexa |
|
|
ART5 Polyclonal Antibody, HRP Conjugated |
|||
| A66467-050 | EpiGentek | 50 ul | EUR 302.5 |
ART5 Polyclonal Antibody, HRP Conjugated |
|||
| A66467-100 | EpiGentek | 100 ul | EUR 423.5 |
ART5 Polyclonal Antibody, FITC Conjugated |
|||
| A66468-050 | EpiGentek | 50 ul | EUR 302.5 |
ART5 Polyclonal Antibody, FITC Conjugated |
|||
| A66468-100 | EpiGentek | 100 ul | EUR 423.5 |
ART5 Polyclonal Antibody, Biotin Conjugated |
|||
| A66469-050 | EpiGentek | 50 ul | EUR 302.5 |
ART5 Polyclonal Antibody, Biotin Conjugated |
|||
| A66469-100 | EpiGentek | 100 ul | EUR 423.5 |
ART5 Polyclonal Antibody, HRP Conjugated |
|||
| A66467 | EpiGentek |
|
|
ART5 Polyclonal Antibody, FITC Conjugated |
|||
| A66468 | EpiGentek |
|
|
ART5 Polyclonal Antibody, Biotin Conjugated |
|||
| A66469 | EpiGentek |
|
|
Human ART5 shRNA Plasmid |
|||
| 20-abx964539 | Abbexa |
|
|
Mouse ART5 shRNA Plasmid |
|||
| 20-abx969241 | Abbexa |
|
|
Rat ART5 shRNA Plasmid |
|||
| 20-abx988042 | Abbexa |
|
|
ART5 ELISA KIT|Human |
|||
| EF007924 | Lifescience Market | 96 Tests | EUR 826.8 |
ART5 Recombinant Protein (Rat) |
|||
| RP191087 | ABM | 100 ug | Ask for price |
ART5 Recombinant Protein (Human) |
|||
| RP001990 | ABM | 100 ug | Ask for price |
ART5 Recombinant Protein (Mouse) |
|||
| RP117383 | ABM | 100 ug | Ask for price |
Ecto-ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| abx230615-100ug | Abbexa | 100 ug | EUR 610.8 |
Ecto-ADP-Ribosyltransferase 5 (ART5) Antibody |
|||
| 20-abx302484 | Abbexa |
|
|
Ecto-ADP-Ribosyltransferase 5 (ART5) Antibody (HRP) |
|||
| 20-abx309159 | Abbexa |
|
|
Ecto-ADP-Ribosyltransferase 5 (ART5) Antibody (FITC) |
|||
| 20-abx309160 | Abbexa |
|
|
Ecto-ADP-Ribosyltransferase 5 (ART5) Antibody (Biotin) |
|||
| 20-abx309161 | Abbexa |
|
|
ART5 ELISA Kit (Human) (OKEH07850) |
|||
| OKEH07850 | Aviva Systems Biology | 96 Wells | EUR 1075.2 |
|
Description: Description of target: The protein encoded by this gene belongs to the ARG-specific ADP-ribosyltransferase family. Proteins in this family regulate the function of target proteins by attaching ADP-ribose to specific amino acid residues in their target proteins. The mouse homolog lacks a glycosylphosphatidylinositol-anchor signal sequence and is predicted to be a secretory enzyme. Several transcripts encoding different isoforms have been found for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 1.63ng/mL |
|||
Art5 ORF Vector (Rat) (pORF) |
|||
| ORF063697 | ABM | 1.0 ug DNA | EUR 607.2 |
ART5 ORF Vector (Human) (pORF) |
|||
| ORF000664 | ABM | 1.0 ug DNA | EUR 114 |
Art5 ORF Vector (Mouse) (pORF) |
|||
| ORF039129 | ABM | 1.0 ug DNA | EUR 607.2 |
Art5 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7389301 | ABM | 3 x 1.0 ug | EUR 406.8 |
ART5 sgRNA CRISPR Lentivector set (Human) |
|||
| K0129401 | ABM | 3 x 1.0 ug | EUR 406.8 |
Art5 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4792201 | ABM | 3 x 1.0 ug | EUR 406.8 |
Human ADP-Ribosyltransferase 5 (ART5) ELISA Kit |
|||
| 20-abx385881 | Abbexa |
|
|
Art5 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K7389302 | ABM | 1.0 ug DNA | EUR 184.8 |
Art5 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K7389303 | ABM | 1.0 ug DNA | EUR 184.8 |
Art5 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K7389304 | ABM | 1.0 ug DNA | EUR 184.8 |
ART5 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0129402 | ABM | 1.0 ug DNA | EUR 184.8 |
ART5 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0129403 | ABM | 1.0 ug DNA | EUR 184.8 |
ART5 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0129404 | ABM | 1.0 ug DNA | EUR 184.8 |
Art5 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K4792202 | ABM | 1.0 ug DNA | EUR 184.8 |
Art5 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K4792203 | ABM | 1.0 ug DNA | EUR 184.8 |
Art5 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K4792204 | ABM | 1.0 ug DNA | EUR 184.8 |
ART5 Protein Vector (Human) (pPB-C-His) |
|||
| PV002653 | ABM | 500 ng | EUR 394.8 |
ART5 Protein Vector (Human) (pPB-N-His) |
|||
| PV002654 | ABM | 500 ng | EUR 394.8 |
ART5 Protein Vector (Human) (pPM-C-HA) |
|||
| PV002655 | ABM | 500 ng | EUR 394.8 |
ART5 Protein Vector (Human) (pPM-C-His) |
|||
| PV002656 | ABM | 500 ng | EUR 394.8 |
ART5 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV156514 | ABM | 500 ng | EUR 723.6 |
ART5 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV156515 | ABM | 500 ng | EUR 723.6 |
ART5 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV156516 | ABM | 500 ng | EUR 723.6 |
ART5 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV156517 | ABM | 500 ng | EUR 723.6 |
ART5 Protein Vector (Human) (pPB-His-MBP) |
|||
| PV324090 | ABM | 500 ng | EUR 394.8 |
ART5 Protein Vector (Human) (pPB-His-GST) |
|||
| PV324091 | ABM | 500 ng | EUR 394.8 |
ART5 3'UTR Luciferase Stable Cell Line |
|||
| TU001209 | ABM | 1.0 ml | EUR 1672.8 |
Human ADP Ribosyltransferase 5(ART5)ELISA Kit |
|||
| QY-E05168 | Qayee Biotechnology | 96T | EUR 480 |
Art5 3'UTR Luciferase Stable Cell Line |
|||
| TU102174 | ABM | 1.0 ml | Ask for price |
ART5 3'UTR GFP Stable Cell Line |
|||
| TU051209 | ABM | 1.0 ml | EUR 1672.8 |
Art5 3'UTR Luciferase Stable Cell Line |
|||
| TU200944 | ABM | 1.0 ml | Ask for price |
Art5 3'UTR GFP Stable Cell Line |
|||
| TU250944 | ABM | 1.0 ml | Ask for price |
Art5 3'UTR GFP Stable Cell Line |
|||
| TU152174 | ABM | 1.0 ml | Ask for price |
ART5 Protein Vector (Rat) (pPB-C-His) |
|||
| PV254786 | ABM | 500 ng | EUR 723.6 |
ART5 Protein Vector (Rat) (pPB-N-His) |
|||
| PV254787 | ABM | 500 ng | EUR 723.6 |
ART5 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV254788 | ABM | 500 ng | EUR 723.6 |
ART5 Protein Vector (Rat) (pPM-C-His) |
|||
| PV254789 | ABM | 500 ng | EUR 723.6 |
Human Ecto- ADP- ribosyltransferase 5, ART5 ELISA KIT |
|||
| ELI-44798h | Lifescience Market | 96 Tests | EUR 988.8 |
Mouse Ecto- ADP- ribosyltransferase 5, Art5 ELISA KIT |
|||
| ELI-44883m | Lifescience Market | 96 Tests | EUR 1038 |
Bovine Ecto- ADP- ribosyltransferase 5, ART5 ELISA KIT |
|||
| ELI-20660b | Lifescience Market | 96 Tests | EUR 1113.6 |
ART5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV656155 | ABM | 1.0 ug DNA | EUR 616.8 |
ART5 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV656159 | ABM | 1.0 ug DNA | EUR 616.8 |
ART5 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV656160 | ABM | 1.0 ug DNA | EUR 616.8 |
ART5 Protein Vector (Human) (pPM-N-D-C-HA) |
|||
| PV324092 | ABM | 500 ng | EUR 662.4 |
ART5 Protein Vector (Human) (pPM-N-D-C-His) |
|||
| PV324093 | ABM | 500 ng | EUR 662.4 |
Art5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K7389305 | ABM | 3 x 1.0 ug | EUR 451.2 |
ART5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0129405 | ABM | 3 x 1.0 ug | EUR 451.2 |
Art5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K4792205 | ABM | 3 x 1.0 ug | EUR 451.2 |
ART5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV656156 | ABM | 1.0 ug DNA | EUR 616.8 |
ART5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV656157 | ABM | 1.0 ug DNA | EUR 686.4 |
ART5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV656158 | ABM | 1.0 ug DNA | EUR 686.4 |
Art5 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K7389306 | ABM | 1.0 ug DNA | EUR 200.4 |